Research Library

Fellow Katharine Neill Harris testified before the U.S. House Judiciary Committee on the failed war on drugs and solutions based on racial justice and harm reduction.

What are Mexico's prospects for immigration, trade and more, after President Andrés Manuel López Obrador's virtual meeting with President Biden? "Mexico will have to do some heavy lifting," predicts Tony Payan, director of the Center for the United States and Mexico.

Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.

Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.

In this brief, public finance fellow Jorge Barro explains some of the long-term economic impacts of the COVID-19 pandemic and argues that policymakers can prepare for the impending macroeconomic shortfalls by maintaining a commitment to improving education, prioritizing immigration and resolving fiscal imbalances.

The author draws links between pandemics, the economy, nature and energy, showing that policies reducing the probability of future pandemics are a solid investment.

Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.

As the Budget Control Act nears expiry, it is important to reflect on its effectiveness — does the BCA provide a framework for curtailing unsustainable deficits and moving to a sustainable fiscal policy?  Read the authors' analysis at the Baker Institute Blog.

If the global economy is to recover after the pandemic, the United States must reestablish mutually beneficial economic relations with China. But the new administration should be careful to resist unrestrained Chinese "soft power" influence on our education, research and creative industries.

U.S. oil refiners have had a great run this century. But market events in 2020 signal changes to come that will challenge the industry’s global competitiveness, writes fellow in energy and global oil Mark Finley.